A trial of a combination therapy of fecal microbiota transplantation and antibiotics or simple fecal microbiota therapy for ulcerative colitis

A trial of a combination therapy of fecal microbiota transplantation and antibiotics or simple fecal microbiota therapy for ulcerative colitis - A trial of a combination therapy of FMT and antibiotics or FMT for ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014152

Enrollment

Registered

2014-06-04

Start date

2014-06-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

Administration of the fecal material from healthy donors to patients after taking three kinds of antibiotics (Amoxicillin, fosmycin, metronidazole) for two weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Ulcerative colitis patients 2. Donors should be patient's spouse or first or second-degree relatives.

Exclusion criteria

Exclusion criteria: 1. Patients who have severe drug allergy are excluded. 2. Donors who show abnormal findings to the screening tests including blood and feces.

Design outcomes

Primary

Measure	Time frame
safety efficacy	—

Countries

Japan

Contacts

Public ContactDai Ishikawa

Juntendo university school of medicine Department of gastroenterology

dai@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026